Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Exagen Inc (XGN)

Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Exagen Inc. to Participate in Fourth Quarter Investor Conferences GlobeNewswire - Tue Nov 11, 8:00AM CST

CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor...

XGN : 6.19 (-2.06%)
Exagen Inc. Reports Strong Q3 2025 Results GlobeNewswire - Tue Nov 4, 7:00AM CST

CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30,...

XGN : 6.19 (-2.06%)
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence GlobeNewswire - Thu Oct 23, 8:15AM CDT

CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of...

XGN : 6.19 (-2.06%)
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire - Tue Oct 21, 3:05PM CDT

CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30,...

XGN : 6.19 (-2.06%)
KeyBanc Reaffirms Their Buy Rating on Exagen (XGN) Tipranks - Wed Oct 15, 3:46AM CDT

KeyBanc analyst Paul Knight maintained a Buy rating on Exagen today and set a price target of $15.00. The company’s shares closed yesterday at $11.04.Elevate Your Investing Strategy: Take advantage of...

XGN : 6.19 (-2.06%)
Exagen Inc. Reports Strong Q2 2025 Results GlobeNewswire - Tue Jul 29, 7:00AM CDT

CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2025,...

XGN : 6.19 (-2.06%)
Exagen Inc. Appoints Chas McKhann to Board of Directors GlobeNewswire - Thu Jul 17, 3:05PM CDT

CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board...

XGN : 6.19 (-2.06%)
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 GlobeNewswire - Tue Jul 15, 3:05PM CDT

CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc.

XGN : 6.19 (-2.06%)
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics GlobeNewswire - Mon Jun 23, 8:00AM CDT

XGN : 6.19 (-2.06%)
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares GlobeNewswire - Fri May 9, 3:05PM CDT

XGN : 6.19 (-2.06%)

Barchart Exclusives

Have a MERRY Christmas With These 9 Unusually Active Options Barchart - Thu Dec 25, 12:30PM CST
In the past year, there have been many interesting stocks and their unusually active options to discuss. Whether you do or don’t celebrate Christmas, here are nine stocks whose unusually active options make for good bets in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot